SOP Guide for Pharma

SOP for Dissolution Profile Comparison in Formulation Screening

Auditor

SOP for Dissolution Profile Comparison in Formulation Screening

Standard Operating Procedure (SOP) for Dissolution Profile Comparison in Formulation Screening

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the process for comparing dissolution profiles of different pharmaceutical formulations during screening. Dissolution testing is an essential tool in the development of oral drug dosage forms, as it helps determine the rate and extent of drug release from the formulation. This SOP provides guidelines for conducting dissolution profile comparisons to ensure formulation optimization and to support regulatory submissions by demonstrating the equivalence of formulations.

2) Scope

This SOP applies to all personnel involved in the dissolution testing and comparison of pharmaceutical formulations. It covers the preparation of dissolution test samples, execution of dissolution tests, and the interpretation of results to evaluate the performance of different formulations. This SOP is relevant to formulation scientists, laboratory technicians, and quality control (QC) analysts involved in the screening and development of drug formulations.

3) Responsibilities

  • Formulation Scientists: Oversee the dissolution testing process, ensuring that the appropriate formulations are selected and that the dissolution profiles are analyzed accurately for further development.
  • Laboratory Technicians: Prepare the dissolution test samples, conduct the testing according to the protocol, and record the results for analysis.
  • Quality
Control (QC): Ensure that dissolution testing is performed according to established guidelines, and that the results meet the acceptance criteria for the formulations under study.
  • Project Managers: Coordinate the dissolution testing process, ensuring that resources are effectively allocated and timelines are met for formulation development.

    • 4) Procedure

    The following steps outline the procedure for conducting dissolution profile comparisons in formulation screening:

    1. Step 1: Define Dissolution Testing Requirements
      1. Identify the formulation(s) to be tested and the type of dissolution profile required (e.g., immediate release, controlled release, sustained release).
      2. Establish the dissolution medium and conditions based on the type of formulation, API characteristics, and intended therapeutic use (e.g., pH of medium, temperature, rotation speed, and time intervals).
      3. Define the acceptance criteria for the dissolution profile, including the percentage of drug released at specific time points (e.g., at 30 minutes, 60 minutes, or 90 minutes).
    2. Step 2: Preparation of Dissolution Test Samples
      1. Prepare the formulation samples to be tested, ensuring consistency in the number of dosage units and the correct API concentration for testing.
      2. If the formulation is a tablet or capsule, ensure that the units are uniform and free from any visible defects, such as cracks or discoloration.
      3. If testing liquid formulations, ensure that the solution is homogeneous and that any particulate matter is removed before testing.
    3. Step 3: Conduct Dissolution Testing
      1. Place the dissolution test samples into the dissolution apparatus, ensuring proper alignment and that the sample is adequately immersed in the dissolution medium.
      2. Set the dissolution apparatus parameters (e.g., temperature, rotation speed) according to the established test conditions.
      3. At the defined time intervals, withdraw samples of the dissolution medium, ensuring that each sample is adequately filtered to remove any particles or undissolved material.
      4. Measure the API concentration in the dissolution samples using an appropriate analytical technique, such as UV-Vis spectrophotometry, HPLC, or another suitable method.
    4. Step 4: Dissolution Profile Data Collection
      1. Record the amount of drug released at each time point, ensuring accurate data collection and consistency across all dissolution runs.
      2. Plot the dissolution profile as the cumulative percentage of drug released versus time for each formulation.
      3. Ensure that each test is performed in triplicate to ensure reproducibility and reliable results.
    5. Step 5: Compare Dissolution Profiles
      1. Analyze the dissolution profiles of different formulations, comparing the percentage of drug released at specific time points.
      2. Evaluate the similarity between the profiles using statistical methods, such as the similarity factor (f2), to determine if the dissolution profiles are equivalent or if significant differences exist.
      3. If there are differences, assess whether they are acceptable based on the pre-established criteria and whether formulation adjustments are required.
    6. Step 6: Stability and Performance Evaluation
      1. If needed, conduct stability testing of the formulations to assess the impact of storage conditions on the dissolution profile.
      2. Evaluate whether any formulation changes affect the dissolution profile and make necessary adjustments to optimize the formulation for consistent drug release.
    7. Step 7: Documentation and Reporting
      1. Document all dissolution testing procedures, including sample preparation, testing conditions, data collected, and statistical analysis.
      2. Prepare a report summarizing the dissolution profiles, comparison results, and any recommendations for further optimization of the formulations.
      3. Ensure that all records are signed, dated, and stored in compliance with Good Laboratory Practices (GLP) and regulatory standards.
    8. Step 8: Sample Disposal
      1. Dispose of any remaining dissolution samples, solvents, and materials according to safety protocols and environmental regulations.
      2. Ensure that hazardous materials are disposed of in designated chemical waste containers in compliance with safety guidelines.

    5) Documents

    The following documents should be maintained during dissolution profile comparison testing:

    1. Dissolution Test Records
    2. Data Analysis and Statistical Reports
    3. Dissolution Profile Comparison Report
    4. Sample Preparation and Testing Protocol
    5. Sample Disposal Records

    6) Abbreviations

    • API: Active Pharmaceutical Ingredient
    • GLP: Good Laboratory Practices
    • HPLC: High-Performance Liquid Chromatography
    • USP: United States Pharmacopeia
    • f2: Similarity Factor

    7) References

    References to regulatory guidelines and scientific literature that support this SOP:

    • FDA Guidance for Pharmaceutical Development
    • USP <711> on Dissolution Testing
    • ICH Q8(R2) Pharmaceutical Development

    8) Version

    Version 1.0: Initial version of the SOP.

    9) Annexure

    Dissolution Profile Comparison Results Template

    Formulation ID Time Points (min) Cumulative Drug Release (%) Similarity Factor (f2) Comparison Conclusion
    See also  SOP for Screening Excipients for Formulation Development
    Exit mobile version